Six clinical commissioning groups (CCGs) across south east London will soon be able to access VisualDX’s AI-powered visual diagnostic tool, as per terms of a deal between the NHS and the healthcare software company.

The move, which focuses on enhancing diagnostic accuracy and aiding therapeutic decisions and diagnosis, marks a first for VisualDX, as it launches its first foothold into the UK’s National Health Service (NHS).

Art Papier, chief executive officer of VisualDX, said: “This agreement with NHS CCGs in South East London helps patients and clinicians alike to share in the decision-making process to optimise patient-centred outcomes in the pursuit of clinical excellence.”

According to the ECRI Institute, misdiagnoses took the top spot for safety concern among patients.

While the cause for each misdiagnosis varies, VisualDX has build a library of more than 41,000 peer-reviewed medical images to help physicians, especially generalists, to make better informed diagnoses by allowing direct imagery comparison and offering diagnostic possibilities.

Dr Noel Baxter, clinical director for quality and service improvement, NHS Southwark CCG, said: “This agreement with VisualDX further strengthens the support available to general practice in south east London.

“We want our patients to receive the right care, in the right setting, first time and we believe this tool will support general practitioners in their decision making.”

The one-year license covers all GP practices in Bexley, Bromley, Greenwich, Lambeth, Lewisham and Southwark and the tool is available on computers, smartphones, or tablets.

Digital inspiration for pharma on mobile, social media, strategy, best practice, regulations and more